Two large asset managers (BlackRock at 5.2% and Franklin Templeton at 6.0%) have now disclosed 5%+ passive stakes in JBIO within two days, signaling growing institutional interest. Monitor for additional 13G filings from other major holders and any subsequent 13D conversion if activist intent emerges.
Price Chart
Executive Summary
Franklin Templeton, Inc. filed a new Schedule 13G disclosing beneficial ownership of 3,807,236 shares of Jade Biosciences, Inc. common stock, representing 6.0% of shares outstanding as of September 30, 2026. This is a passive investment filing with no activist intent, and Franklin Templeton certifies the shares were acquired in the ordinary course of business. The disclosure follows a prior 13G filing by BlackRock one day earlier, showing growing institutional interest in JBIO.
Key Financial Metrics
Key Facts
- Franklin Templeton, Inc. filed a new Schedule 13G on October 28, 2026
- Beneficial ownership of 3,807,236 shares of Jade Biosciences common stock
- Represents 6.0% of shares outstanding as of September 30, 2026
- Passive investment, shares acquired in ordinary course of business, no activist intent
- Franklin Templeton's subsidiaries holding shares include Franklin Advisers, Inc. (2,004,120 shares), Franklin Mutual Advisers, LLC (1,702,377 shares), and Fiduciary Trust International LLC (35 shares)
- This follows a BlackRock 13G filed one day earlier disclosing a 5.2% stake
Financial Impact
Franklin Templeton holds a 6.0% stake in JBIO, valued at approximately $55.3 million based on a $922M market cap
Risk Factors
- No activist intent disclosed; stake is passive and does not signal a change in control or strategy
- Franklin Templeton's holdings are spread across multiple subsidiaries with independent voting and investment discretion
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000038777-26-000277 |
| Document: 0000038777-26-000277-index.html | 0000038777-26-000277 |
| Document: 0000038777-26-000277.txt | 0000038777-26-000277 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 28, 2026 1d ago | SC 13G | $14.59 | awaiting T+5 | awaiting T+5 | $14.24 (−2.40%) |
Oct 27, 2026 2d ago | SC 13G | $14.59 | awaiting T+5 | awaiting T+5 | $14.24 (−2.40%) |
Sep 30, 2026 29d ago | 8-K | $14.05 $13.77 | ▼ −1.99% | ▼ −3.91% | $14.24 (+1.35%) |
Aug 10, 2026 11w ago | 8-K | No price | awaiting T+5 | awaiting T+5 | No price |
Aug 10, 2026 11w ago | Press Release | $21.73 $23.45 | ▲ +7.92% | ▲ +7.96% | $14.24 (−34.47%) |
Jun 5, 2026 20w ago | Press Release | $14.98 $16.10 | ▼ −7.48% | ▼ −5.37% | $14.24 (+4.94%) |
Jun 4, 2026 21w ago | 8-K | $16.94 $15.34 | ▲ +9.45% | ▲ +10.01% | $14.24 (+15.94%) |
Jun 4, 2026 21w ago | 424B5 | $16.94 $15.34 | ▲ +9.45% | ▲ +10.01% | $14.24 (+15.94%) |
Jun 3, 2026 21w ago | Press Release | $17.74 $16.08 | ▲ +9.36% | ▲ +6.80% | $14.24 (+19.73%) |
Jun 3, 2026 21w ago | 424B5 | $17.74 $16.08 | ▲ +9.36% | ▲ +6.80% | $14.24 (+19.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers